Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Prime Medicine Inc
(NQ:
PRME
)
5.610
-0.040 (-0.71%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
508,146
Open
5.780
Bid (Size)
5.570 (10)
Ask (Size)
5.890 (1)
Prev. Close
5.650
Today's Range
5.520 - 5.950
52wk Range
4.110 - 15.75
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Prime Medicine to Present at Upcoming Investor Conferences
May 30, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names
May 29, 2024
Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.
Via
InvestorPlace
Exposures
Product Safety
Performance
YTD
-35.96%
-35.96%
1 Month
+5.25%
+5.25%
3 Month
+15.43%
+15.43%
6 Month
-25.10%
-25.10%
1 Year
-62.20%
-62.20%
More News
Read More
Here Are the 2 Growth Stocks Google's Parent Company Just Added to Its $7 Billion Portfolio
May 25, 2024
Via
The Motley Fool
Wall Street Favorites: 3 Cathie Wood Stocks With Strong Buy Ratings for May 2024
May 17, 2024
Via
InvestorPlace
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
May 17, 2024
Via
InvestorPlace
Recap: Prime Medicine Q4 Earnings
March 01, 2024
Via
Benzinga
Prime Medicine to Present at H.C. Wainwright 2nd Annual BioConnect Investor Conference at NASDAQ
May 13, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
PRME Stock Earnings: Prime Medicine Beats EPS for Q1 2024
May 10, 2024
Via
InvestorPlace
Prime Medicine Reports First Quarter 2024 Financial Results and Provides Business Updates
May 10, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Presents Preclinical Data Demonstrating Ability of PM359 to Efficiently, Reproducibly and Durably Correct Causative Mutation of Chronic Granulomatous Disease (CGD)
May 08, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
May 02, 2024
Via
Benzinga
Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
May 01, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 29, 2024
Via
Benzinga
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
April 29, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 29, 2024
Via
InvestorPlace
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
April 29, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
April 26, 2024
Via
Benzinga
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
April 23, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
2 Magnificent Growth Stocks With Room to Run
March 27, 2024
Via
The Motley Fool
Short-Squeeze Roulette: 3 Stocks That Could Leave Bears Begging
March 14, 2024
Via
InvestorPlace
Cathie Wood Just Bought These 3 Biotech Stocks. Should You Buy, Too?
March 01, 2024
Via
InvestorPlace
Prime Medicine Reports Full Year 2023 Financial Results and Provides Business Updates
March 01, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine to Participate in Upcoming Investor Conferences
February 28, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
February 20, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Prime Medicine Announces Pricing of Upsized Public Offering
February 14, 2024
From
Prime Medicine, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.